For the first time, scientists from the German Cancer Consortium (DKTK) partner site in Essen/Düsseldorf have discovered stem cells of the hematopoietic system in glioblastomas, the most aggressive form of brain tumor. These ...
Jun 28, 2021
0
6
Prostate cancer is the second most common cancer among men, according to the American Cancer Society. It's also one of the trickiest cancers to diagnose and treat.
Jun 10, 2021
0
22
Published in the Advanced Functional Materials, University of Minnesota researcher Hongbo Pang led a cross-institutional study on improving the efficacy of nucleotide-based drugs against prostate cancer and bone metastasis.
Apr 20, 2021
0
21
Two studies led by Baylor College of Medicine shed new light on the unanswered question of why estrogen receptor-positive (ER+) breast cancer sometimes grows back in the bone and spreads to other tissues despite effective ...
Apr 19, 2021
0
81
A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have ...
Apr 11, 2021
0
152
(HealthDay)—Nearly one in five children might have benign bone tumors of the extremities, according to a study published in the March 1 issue of the Journal of Bone & Joint Surgery.
Apr 2, 2021
0
0
A minimally invasive treatment for patients whose cancer has spread to their bones provides quick and sustained pain relief and improves quality of life, according to a new study to be presented at the Society of Interventional ...
Mar 16, 2021
0
4
Benign bone tumors may be present in nearly 20 percent of healthy children, based on a review of historical radiographs in The Journal of Bone & Joint Surgery.
Mar 2, 2021
0
2
A radioactive bone cement that's injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a study led by University of ...
Feb 16, 2021
0
16
A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it eliminate tumor cells through the use of nanobiologics, tiny materials ...
Oct 29, 2020
0
236
